1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

12 Dec 2019
Admin
News Article

Gemini Therapeutics And Avitide Enter Into Exclusive License Agreement

Avitide, Inc., The Industry Leader In The Discovery And Development Of Custom Affinity Purification Resins, Announces That It Has Entered Into An Exclusive License Agreement To Support The Development Of One Of Gemini Therapeutics' Therapeutic Programs."While Antibodies Have A Relatively Straightforward Path Through Development, Non-Antibody Biopharmaceuticals Do Not. We Anticipated Challenges And Partnered With Avitide To De-Risk Our Lead Program And Accelerate Preclinical Development. Avitide Supplied Resins For Process Development, Toxicology Lot And Cgmp Manufacturing In Sync With Our Cdmo Timelines. Given The Success Of Our First Partnership, We Look To Expand The Relationship To Include Other Therapeutic Programs Within The Gemini Portfolio," Said Scott Lauder, Gemini Therapeutics' Chief Technology Officer.The License Agreement Grants Gemini Therapeutics Exclusive Rights To Specific Avitide Affinity Resins For Use In Preclinical, Clinical And Commercial Manufacturing. In Turn, Avitide Retains Exclusivity For The Manufacture And Supply Of The Affinity Resins To Gemini Therapeutics."Bioprocess Development Is Often On The Critical Path For Any Biopharmaceutical Drug Entering The Clinic; Establishing An Initial Purification Process That Does Not Have Line-Of-Sight To Commercial Manufacturing Can Carry Significant Costs And Regulatory Risks. Gemini Recognized These Risks From The Onset And Elected To Work With Avitide To De-Risk Their Overall Development Path. We Look Forward To Continuing The Relationship With Gemini To Help Get This Important Therapy To The Clinic," Said Kevin Isett, Avitide'S Chief Executive Officer.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!